ATE465242T1 - Exogene angiogene wachstumsfaktoren exprimierende keratinozyten - Google Patents

Exogene angiogene wachstumsfaktoren exprimierende keratinozyten

Info

Publication number
ATE465242T1
ATE465242T1 AT03726524T AT03726524T ATE465242T1 AT E465242 T1 ATE465242 T1 AT E465242T1 AT 03726524 T AT03726524 T AT 03726524T AT 03726524 T AT03726524 T AT 03726524T AT E465242 T1 ATE465242 T1 AT E465242T1
Authority
AT
Austria
Prior art keywords
growth factors
angiogenic growth
keratinocytes
skin tissue
cultured skin
Prior art date
Application number
AT03726524T
Other languages
English (en)
Inventor
Allen Comer
Michael Hoffmann
Lynn-Allen Hoffmann
Original Assignee
Stratatech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stratatech Corp filed Critical Stratatech Corp
Application granted granted Critical
Publication of ATE465242T1 publication Critical patent/ATE465242T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/17—Angiopoietin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Prostheses (AREA)
AT03726524T 2002-04-30 2003-04-29 Exogene angiogene wachstumsfaktoren exprimierende keratinozyten ATE465242T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37648802P 2002-04-30 2002-04-30
PCT/US2003/013327 WO2003093418A2 (en) 2002-04-30 2003-04-29 Keratinocytes expressing exogenous angiogenic growth factors
US10/425,784 US7498167B2 (en) 2002-04-30 2003-04-29 Keratinocytes expressing exogenous angiogenic growth factors

Publications (1)

Publication Number Publication Date
ATE465242T1 true ATE465242T1 (de) 2010-05-15

Family

ID=29406758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726524T ATE465242T1 (de) 2002-04-30 2003-04-29 Exogene angiogene wachstumsfaktoren exprimierende keratinozyten

Country Status (9)

Country Link
US (5) US7498167B2 (de)
EP (1) EP1549738B1 (de)
JP (1) JP4753577B2 (de)
AT (1) ATE465242T1 (de)
CA (1) CA2483547C (de)
DE (1) DE60332256D1 (de)
IL (3) IL164817A0 (de)
NZ (1) NZ536205A (de)
WO (1) WO2003093418A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60332256D1 (de) 2002-04-30 2010-06-02 Stratatech Corp Exogene angiogene wachstumsfaktoren exprimierende keratinozyten
CA2600177C (en) * 2005-03-01 2011-06-14 Stratatech Corporation Human skin equivalents expressing exogenous polypeptides
US20090145087A1 (en) 2007-11-14 2009-06-11 Stratatech Corporation Cold storage of organotypically cultured skin equivalents for clinical applications
JP5632383B2 (ja) * 2008-11-04 2014-11-26 ストラタテック コーポレーション 即時使用のための乾燥され、放射線照射された皮膚同等物
US20100330046A1 (en) * 2009-05-21 2010-12-30 Stratatech Corporation Human skin substitutes expressing il-12
TWI488966B (zh) * 2010-07-09 2015-06-21 優普生物科技股份有限公司 Ｄｎａ疫苗
US9597111B2 (en) 2010-08-06 2017-03-21 Kci Licensing, Inc. Methods for applying a skin graft
US8978234B2 (en) 2011-12-07 2015-03-17 MoMelan Technologies, Inc. Methods of manufacturing devices for generating skin grafts
JP2012205516A (ja) * 2011-03-29 2012-10-25 Osaka Univ 人工皮膚モデルの製造方法、及び人工皮膚モデル
US9663564B2 (en) 2013-03-15 2017-05-30 The Regents Of The University Of California Vectors and methods to treat ischemia
US20140065110A1 (en) 2012-08-31 2014-03-06 The Regents Of The University Of California Genetically modified msc and therapeutic methods
WO2014072941A1 (en) 2012-11-09 2014-05-15 Marco Archetti Diffusible factors and cancer cells
EP3470018B1 (de) 2013-03-13 2021-07-28 Stratatech Corporation Kryokonservierung lebensfähiger menschlicher hautsubstitute
JP6491188B2 (ja) 2013-03-14 2019-03-27 ケーシーアイ ライセンシング インコーポレイテッド 皮膚移植片採取用の吸収性基材
EP3089681B1 (de) 2013-12-31 2021-09-08 3M Innovative Properties Company Flüssigkeitsunterstützte entnahme eines hautimplantats
US9993261B2 (en) 2013-12-31 2018-06-12 Kci Licensing, Inc. Sensor systems for skin graft harvesting
SG11201703582VA (en) * 2014-10-30 2017-05-30 Indian Council Medical Res A method for processing of feeder cells suitable for adult stem cell proliferation
WO2016164890A1 (en) 2015-04-09 2016-10-13 Kci Licensing, Inc. Soft-tack, porous substrates for harvesting skin grafts
EP3370630B1 (de) 2015-11-03 2021-06-16 3M Innovative Properties Company Vorrichtung zur herstellung einer epidermalen transplantatfolie
WO2017143229A1 (en) * 2016-02-19 2017-08-24 Kci Licensing, Inc. Transfected epidermal grafts and methods of making the same
WO2018107064A1 (en) * 2016-12-09 2018-06-14 The University Of Chicago Tissue organoids
JP2022549688A (ja) * 2019-09-27 2022-11-28 ストラタテック コーポレーション 急性創傷を治療し、転帰を改善するための方法
IL297372A (en) * 2020-05-13 2022-12-01 Stratatech Corp Sustainable bioengineered skin constructs
US20240207487A1 (en) * 2021-06-08 2024-06-27 Stratatech Corporation Viable bioengineered allogeneic cellularized skin constructs that secrete soluble factors associated with regenerative wound healing
CN118139655A (zh) * 2021-08-13 2024-06-04 特里奥万斯控股公司 皮肤替代组合物及其产生和使用方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US448096A (en) * 1891-03-10 Hydrant
US4485096A (en) * 1982-02-26 1984-11-27 Massachusetts Institute Of Technology Tissue-equivalent and method for preparation thereof
IL95429A (en) * 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
US5292655A (en) * 1990-01-29 1994-03-08 Wille Jr John J Method for the formation of a histologically-complete skin substitute
CA2080693C (en) * 1990-04-24 2001-11-27 Mark Eisenberg Composite living skin equivalents
US5292566A (en) * 1990-05-22 1994-03-08 National Label Company Battery label with non-shrinkable top layer
IT1248934B (it) * 1990-06-01 1995-02-11 Fidia Spa Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
US5693332C1 (en) * 1995-08-11 2001-01-09 Univ California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5968546A (en) * 1997-05-16 1999-10-19 Baur; Marcus Keratinocyte culture from precursor cells
US20010048917A1 (en) * 1998-03-09 2001-12-06 Warren Hoeffler Skin equivalent and methods of forming and using same
US5989837A (en) * 1998-07-13 1999-11-23 Wisconsin Alumni Research Foundation Immortalized human keratinocyte cell line
US20030152562A1 (en) * 2001-10-23 2003-08-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Vitro micro-organs, and uses related thereto
US6458382B1 (en) * 1999-11-12 2002-10-01 Mirus Corporation Nucleic acid transfer complexes
US6793918B2 (en) * 2000-11-01 2004-09-21 Ludwig Institute For Cancer Research In vivo stimulation of angiogenic activity
WO2002070729A2 (en) * 2001-03-02 2002-09-12 Stratatech Corporation Improved skin substitutes and uses thereof
US6849718B2 (en) * 2001-03-20 2005-02-01 Dana Farber Cancer Institute, Inc. Muteins of hypoxia inducible factor alpha and methods of use thereof
AU2002313559A1 (en) * 2001-08-23 2003-03-10 Oxford Biomedica (Uk) Limited Genes
US6838430B2 (en) * 2001-09-28 2005-01-04 The Regents Of The University Of California Use of HIF-1a variants to accelerate wound healing
US20040190793A1 (en) * 2002-03-01 2004-09-30 Rorvig Mark E. Method for retrieving images by content measure metadata encoding
DE60332256D1 (de) * 2002-04-30 2010-06-02 Stratatech Corp Exogene angiogene wachstumsfaktoren exprimierende keratinozyten
WO2004013606A2 (en) * 2002-08-02 2004-02-12 Stratatech Corporation Species specific dna detection
JP2006526413A (ja) * 2003-05-30 2006-11-24 ストラタテック コーポレーション 臓器の室温保存法
EP3100611B1 (de) * 2003-08-01 2018-09-12 Stratatech Corporation Exogene polypeptide exprimierende äquivalente menschlicher haut

Also Published As

Publication number Publication date
AU2003228755A1 (en) 2003-11-17
US7988959B2 (en) 2011-08-02
CA2483547A1 (en) 2003-11-13
EP1549738A2 (de) 2005-07-06
US7807148B2 (en) 2010-10-05
US7915042B2 (en) 2011-03-29
WO2003093418A2 (en) 2003-11-13
IL164817A (en) 2010-12-30
JP4753577B2 (ja) 2011-08-24
NZ536205A (en) 2008-04-30
US20040009591A1 (en) 2004-01-15
DE60332256D1 (de) 2010-06-02
IL195518A (en) 2012-08-30
US20110286985A1 (en) 2011-11-24
US20050013807A1 (en) 2005-01-20
EP1549738A4 (de) 2006-11-02
JP2006509529A (ja) 2006-03-23
WO2003093418A3 (en) 2005-04-21
US7498167B2 (en) 2009-03-03
US20090169528A1 (en) 2009-07-02
US20110059057A1 (en) 2011-03-10
EP1549738B1 (de) 2010-04-21
IL164817A0 (en) 2005-12-18
CA2483547C (en) 2012-03-20
US8808685B2 (en) 2014-08-19

Similar Documents

Publication Publication Date Title
DE60332256D1 (de) Exogene angiogene wachstumsfaktoren exprimierende keratinozyten
WO2020186207A3 (en) Non-viral dna vectors and uses thereof for expressing fviii therapeutics
MX2007005200A (es) Plaquetas a partir de celulas germinales.
Kang et al. Effect of mechanical stimulation on the differentiation of cord stem cells
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
BR0306665A (pt) Uso de zeìna nativa para aperfeiçoamento do estado do cabelo e agentes
MX2010001564A (es) Uso de una globina, un promotor de globina o una hemoglobina extracelular para la conservacion de organos, tejidos o celulas de organos o de tejidos o de cultivo de celulas.
ATE465255T1 (de) Verabreichung von sirnas
DE60238058D1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
MXPA05008216A (es) Medios para mejorar la apariencia del tejido queratinoso mamifero.
DE69922933D1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
Agabalyan et al. Hair follicle dermal stem cells and skin‐derived precursor cells: Exciting tools for endogenous and exogenous therapies
WO2005012492A3 (en) Human skin equivalents expressing exogenous polypeptides
WO2004007695A3 (en) Lactobacilli expressing biologically active polypeptides and uses thereof
DK1506301T3 (da) Rekombinant poxvirus, der udtrykker homologe gener, der er indsat i poxvirusgenomet
ATE373082T1 (de) Pre-adipose zelllinien
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
MX2021011037A (es) Vectores de adn no virales y usos de estos para expresar agentes terapéuticos de fenilalanina hidroxilasa (pah).
MXPA03001673A (es) Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.
MX2022011805A (es) Vectores de adn no virales y usos de estos para expresar agentes terapéuticos con factor ix.
ATE514771T1 (de) Haartransplantation
WO2006094070A3 (en) Human skin equivalents expressing exogenous polypeptides
ATE493966T1 (de) Mittel zur förderung der hautkollagenproduktion
TW200738752A (en) Modulation of MDL-1 activity for treatment of inflammatory disease
TW200621293A (en) Cosmetic compositions containing fluorescent colorants for natural skin appearance

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties